Bannière d'en-têteBannière d'en-tête

ASTM F1980 - Accelerated Aging of Sterile Barrier Systems & Medical Devices

In the realm of medical device packaging and sterilization, ASTM F1980 has stood as a cornerstone standard. This guide details the accelerated aging process of sterile barrier systems, a critical step in ensuring the safety and effectiveness of medical devices. The guide revision, ASTM F1980-21, has introduced pivotal changes, underscoring the evolution of standards in response to technological advancements and deeper material insights. Evaluating the product package is essential to ensure the safety of medical device users.

1: Understanding ASTM F1980

1.1: What is ASTM F1980?

ASTM F1980, formally titled "Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices," serves as a critical protocol in the medical device industry. It outlines a methodical approach for simulating the aging process of medical device packaging, which is essential for assessing the long-term integrity and efficacy of sterile barrier systems (SBS). This standard provides a framework for predicting how these systems will hold up over time, ensuring that medical devices remain sterile and functional throughout their intended shelf life.

1.2: The importance of ASTM F1980 testing

The significance of ASTM F1980 testing extends beyond mere compliance. It is integral to patient safety and product reliability. Sterile barrier systems are the first line of defense in protecting medical devices from microbial contamination and environmental factors that can compromise their sterility. By accurately simulating aging conditions, ASTM F1980 testing allows manufacturers to predict and validate the shelf life of their products. This not only helps in maintaining high standards of quality and safety but also aids in efficient inventory management and reduces the risk of product recalls due to packaging failures. Moreover, adherence to this standard is often a prerequisite for regulatory approvals and market acceptance, making it an indispensable aspect of medical device production and distribution.

2: The ASTM F1980-21 revision

2.1: Key updates in the 2021 revision

The 2021 update of the ASTM F1980 standard, known as ASTM F1980-21, introduced noteworthy changes that reflect the evolving understanding of sterile packaging's role in medical device safety. The primary revision in this update is the recommendation for considering controlled humidity during the accelerated aging process. This shift acknowledges that the properties of packaging materials can be significantly affected by humidity levels, which in turn can impact the sterility and efficacy of the enclosed medical device. By incorporating this aspect, ASTM F1980-21 provides a more comprehensive approach to aging testing, aligning with the real-world conditions that medical devices might encounter during their shelf life.

2.2: Implications for medical device manufacturers

The introduction of controlled humidity considerations in ASTM F1980-21 has substantial implications for medical device manufacturers. It mandates a more detailed understanding of the materials used in device packaging and how they interact with environmental factors like humidity. Manufacturers are now expected to not only consider but also document their decisions regarding humidity control during the testing process for each package product. This requirement enhances the robustness of the testing protocol and ensures a more accurate representation of storage and usage conditions. The update also signifies a move towards a more customized testing approach, where the unique properties of each product and its packaging are considered, leading to improved quality assurance and patient safety standards in the industry.

3: Conducting ASTM F1980 testing

3.1: The testing process

The ASTM F1980 testing process is a systematic approach designed to assess the longevity and integrity of Sterile Barrier Systems (SBS) used in medical device packaging. The core of this process is to simulate the aging of the packaging materials under accelerated conditions. This is achieved by exposing the SBS to elevated temperatures, which accelerates the rate of material degradation. This test method allows manufacturers to predict how long the packaging will maintain its integrity and protect the device's sterility under normal storage conditions. The test results are important in determining the shelf life of the medical device, providing essential data for labeling and international regulatory compliance.

3.2: Calculating Accelerated Aging Time

A pivotal part of ASTM F1980 testing is the calculation of the Accelerated Aging Time (AAT). The AAT is determined using the Arrhenius Equation, which correlates the rate of chemical reactions (and thus material aging) to temperature. This equation is used to extrapolate the effects of aging over a longer period, based on observations from a shorter, more intense exposure to heat. Manufacturers must identify the appropriate accelerated aging temperature (TAA) and compare it against the normal ambient temperature (TRT) to calculate the AAT. This calculation helps establish a scientifically valid estimate of the product's shelf life, ensuring that medical devices and their packaging remain safe and effective for their intended lifespan.

Accelerated Aging Time (AAT) = Desired Real Time (RT) Q10 [(TAA − TRT) / 10]

One of the steps involved in conducting ASTM F1980 accelerated aging tests on medical devices is the determination of the Q10 value of the test sample, which quantifies the rate at which a material system undergoes changes with a temperature increase of +10°C.

The Q10 aging factor usually ranges from 1.8 to 2.5, with a frequent value of 2.0.

It is not advisable to subject packaging materials to temperatures higher than +60ºC for aging purposes. The recommended temperatures for accelerated aging are +50ºC, +55ºC, and +60ºC. Ambient real temperature (TRT) is typically between +20ºC to +25ºC.


SERINGUE en viellisement accéléré


The ASTM F1980 standard suggests conducting accelerated aging tests at temperatures below 60°C. This recommendation is based on the balance between simulating an accelerated aging process and avoiding extreme conditions that could cause unrepresentative degradation of the packaging materials. Manufacturers have to choose a temperature that accurately reflects the product's intended storage and use conditions. Proper balancing of accelerated aging parameters permit to obtain accurate results and avoid rejecting packaging solutions that would be adequate under normal conditions.

Quick access

  • 30-32 Rue Capitaine George Madon

    51100 Reims

  • +33 3 26 89 50 47

    Mon-Fri 9:00-12:00, 14:00-17:00

    Learn more
  • Contact-us

    By email

    Learn more
  • Join us

    Job offers

    Learn more